hypofractionated radiation

hypofractionated radiation

doses of radiation given less frequently than daily.

hy·po·frac·tion·at·ed ra·di·a·tion

(hī'pō-frak'shŭn-ā-tĕd rā'dē-ā'shŭn)
Larger fractions of a dose of radiation given less frequently than daily.
References in periodicals archive ?
The fourth edition highlights new treatment paradigms for the management of multiple disease sites, and reflects updates on dose constraints for stereotactic radiosurgery and hypofractionated radiation doses.
Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas.
A hypofractionated radiation protocol (3-4 fractions of 8 Gy performed once a week; a total of 24-32 Gy) was used.
We set out to check if the accuracy and the precision would be sufficient for future hypofractionated radiation treatments, including radiosurgery for intracranial tumors.
Levine et al., "Long-term results of hypofractionated radiation therapy for breast cancer," The New England Journal of Medicine, vol.
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.
Today, Cleveland Clinic and other centers are using hypofractionated radiation regimens, which significantly reduce the number of treatments.
However, hypofractionated radiation therapy control rate was gradually reported surpassing the traditional fraction significantly.[sup][44] Single-fraction electron beam irradiation of a total dose of 10 Gy was performed in UK, US, and Asia on patients who were refractory to other treatment modalities except for radiotherapy, demonstrating no recurrence and well tolerance.[sup][24],[46],[62] As an experienced single-center treating keloids with postoperative radiation therapy, a total dose of 18 Gy given a week apart in 2 fractions was considered feasible and safe with only <10% chronic adverse effects.
Oliviero et al., "Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: a review," International Journal of Radiation Oncology Biology Physics, vol.
Although the use of hypofractioned WBI has increased since 2008, only 34.5% of the women aged 50 or older with early-stage cancer (endorsed group) and 21.2% of the permitted cohort received hypofractionated radiation therapy in 2013.